Researchers at the U.S. Department of Energy's (DOE's) Joint BioEnergy Institute (JBEI) announced today a major breakthrough in engineering systems of RNA molecules through computer-assisted design, which could lead to important improvements across a range of industries, including the development of cheaper advanced biofuels.
Scientists will use these new "RNA machines", to adjust genetic expression in the cells of microorganisms. This will enable scientists to develop new strains of Escherichia coli (E. coli) that are better able to digest switchgrass biomass and convert released sugars to form three types of transportation fuels – gasoline, diesel and jet fuels.
"This is a perfect example of how our investments in basic science innovations can pave the way for future industries and solutions to our nation's most important challenges," said Energy Secretary Steven Chu. "This breakthrough at the Joint BioEnergy Institute holds enormous potential for the sustainable production of advanced biofuels and countless other valuable goods."
A breakthrough with E. coli could make it cheaper to produce fuel from switchgrass or other non-food biomass plants to create advanced biofuels with the potential to replace gasoline. While the work at JBEI remains focused on the development of advanced biofuels, JBEI's researchers believe that their concepts may help other researchers to develop many other desired products, including biodegradable plastics and therapeutic drugs. For example, some researchers have already started a project to investigate how to use the "RNA machines" to increase the safety and efficacy of medicine therapies to treat diseases, including diabetes and Parkinson's.
Biological systems are incredibly complex, which makes it difficult to engineer systems of microorganisms that will produce desired products in predictable amounts. JBEI's work, which will be featured in the December 23rd issue of Science magazine, is the first of its kind to set up and adjust a RNA system in a predictable way.
Specifically, researchers focused their design-driven approach on RNA sequences that can fold into complicated three dimensional shapes, called ribozymes and aptazymes. By using JBEI-developed computer-assisted models and simulations, researchers then created complex RNA-based control systems that are able to program a large number of genes. In microorganisms, "commands" that are sent into the cell will be processed by the RNA-based control systems, enabling them to help develop desired products.
One of the major goals of synthetic biology is to produce valuable chemical products from simple, inexpensive and renewable starting materials in a sustainable manner. Computer-assisted models and simulations like the one JBEI developed are essential for doing so. Up to this point, such tools for biology have been very limited and JBEI's breakthrough in applying computer assisted design marks an important technical and conceptual achievement for this field.
To view additional details about this research, visit http://newscenter.lbl.gov/news-releases/2011/12/22/cad-for-rna/.
JBEI, led by the Lawrence Berkeley National Laboratory, is one of three Bioenergy Research Centers established by the DOE's Office of Science in 2007. For more information, visit www.jbei.org
Jeff Sherwood | EurekAlert!
Smart windows that self-illuminate on rainy days
29.05.2020 | Pohang University of Science & Technology (POSTECH)
Skoltech scientists get a sneak peek of a key process in battery 'life'
28.05.2020 | Skolkovo Institute of Science and Technology (Skoltech)
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering